Leendert H. J. Looijenga

71.3k citations

385 papers · 19.9k indexed · 6 hit papers · h-index 74

Molecular Biology top 0.2%
Surgery top 0.05%
Genetics top 0.1%
Reproductive Medicine top 0.05%
Pulmonary and Respiratory Medicine top 0.5%

Co-authors: J. Wolter Oosterhuis Hans Stoop Ad Gillis Martine Cools Katja P. Wolffenbuttel Carsten Bokemeyer Remko Hersmus Friedemann Honecker
Topics: Testicular diseases and treatments (236 papers)Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (82 papers)Sexual Differentiation and Disorders (79 papers)
Cited by: Reproductive Medicine Surgery Urology
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: Netherlands United States Germany

In The Last Decade

Leendert H. J. Looijenga

376 papers receiving 19.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors

2006 1.0k citations Ad Gillis, Hans Stoop et al. profile →
Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care

2016 745 citations Leendert H. J. Looijenga et al. profile →
Testicular germ-cell tumours in a broader perspective

2005 693 citations J. Wolter Oosterhuis, Leendert H. J. Looijenga Nature reviews. Cancer profile →
WHO Classification of of Tumours of the Urinary System and Male Genital Organs

2016 587 citations Leendert H. J. Looijenga, Ewa Rajpert‐De Meyts et al. profile →
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

2003 502 citations Leendert H. J. Looijenga, Hans Stoop et al. profile →
Testicular cancer

2018 302 citations Gedske Daugaard, Leendert H. J. Looijenga et al. profile →

Peers

Countries citing papers authored by Leendert H. J. Looijenga

Since Specialization

Citations

This map shows the geographic impact of Leendert H. J. Looijenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leendert H. J. Looijenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leendert H. J. Looijenga more than expected).

Fields of papers citing papers by Leendert H. J. Looijenga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leendert H. J. Looijenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leendert H. J. Looijenga. The network helps show where Leendert H. J. Looijenga may publish in the future.

Co-authorship network of co-authors of Leendert H. J. Looijenga

This figure shows the co-authorship network connecting the top 25 collaborators of Leendert H. J. Looijenga. A scholar is included among the top collaborators of Leendert H. J. Looijenga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leendert H. J. Looijenga. Leendert H. J. Looijenga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A comprehensive overview of liquid biopsy applications in pediatric solid tumors 2024 ·npj Precision Oncology ·(unknown),(unknown),(unknown),Lennart Kester,Michael T. Meister,Johannes H. M. Merks,Marry M. van den Heuvel‐Eibrink,Max M. van Noesel,József Zsíros,Godelieve A.M. Tytgat,Leendert H. J. Looijenga	6
2	Alkylating agents‐induced gonadotoxicity in prepubertal males: Insights on the clinical and preclinical front 2024 ·Clinical and Translational Science ·(unknown),(unknown),Annelies M. C. Mavinkurve‐Groothuis,Marianne D. van de Wetering,Leendert H. J. Looijenga	4
3	Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors 2021 ·Molecular Oncology ·João Lobo,Vera Constâncio,(unknown),(unknown),Vera Miranda‐Gonçalves,(unknown),(unknown),Rita de Cássia Avellaneda Guimarães,Mariana Cantante,Isaac Braga,Joaquina Maurício,Leendert H. J. Looijenga,Rui Henrique,Cármen Jerónimo	19
4	The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors 2021 ·Journal of Experimental & Clinical Cancer Research ·Vera Miranda‐Gonçalves,João Lobo,(unknown),Daniela Barros‐Silva,Rita de Cássia Avellaneda Guimarães,Mariana Cantante,Isaac Braga,Joaquina Maurício,Christoph Oing,Friedemann Honecker,Daniel Nettersheim,Leendert H. J. Looijenga,Rui Henrique,Cármen Jerónimo	37
5	Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: A systematic review and meta-analysis 2020 ·European Urology Open Science ·(unknown),(unknown),Gedske Daugaard,Thomas Wagner,Katarzyna Jóźwiak,Erica A. Wilthagen,Leendert H. J. Looijenga,R.P. Meijer,J.L.H. Ruud Bosch,Simon Horenblas	1
6	Comparing genome-scale DNA methylation and CNV marks between adult human cultured ITGA6+ testicular cells and seminomas to assess in vitro genomic stability 2020 ·PLoS ONE ·(unknown),Lambert C. J. Dorssers,Peter Henneman,Martin A. Rijlaarsdam,Andrea Venema,Aldo Jongejan,Marcel M. A. M. Mannens,Leendert H. J. Looijenga,Sjoerd Repping,Ans M. M. van Pelt	11
7	Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors 2020 ·Cancers ·João Lobo,(unknown),Daniela Barros‐Silva,Vera Miranda‐Gonçalves,Vânia Camilo,Rita de Cássia Avellaneda Guimarães,Mariana Cantante,Isaac Braga,Joaquina Maurício,Christoph Oing,Friedemann Honecker,Daniel Nettersheim,Leendert H. J. Looijenga,Rui Henrique,Cármen Jerónimo	26
8	Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial 2020 ·British journal of surgery ·Berend J. van der Wilk,Ben M. Eyck,Michail Doukas,Manon C.W. Spaander,Erik J. Schoon,Kausilia K. Krishnadath,Liekele E. Oostenbrug,Sjoerd M. Lagarde,B.P.L. Wijnhoven,Leendert H. J. Looijenga,Katharina Biermann,J.J.B. van Lanschot	11
9	Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors 2020 ·PMC ·Leendert H. J. Looijenga,Theodorus van der Kwast,David J. Grignon,Lars Egevad,Glen Kristiansen,Chia‐Sui Kao,Muhammad T. Idrees	2
10	Human germ cell tumours from a developmental perspective 2019 ·Nature reviews. Cancer ·J. Wolter Oosterhuis,Leendert H. J. Looijenga	185
11	Meiotic arrest occurs most frequently at metaphase and is often incomplete in azoospermic men 2019 ·Fertility and Sterility ·(unknown),Esther Sleddens–Linkels,Marja Ooms,(unknown),Martina Wilke,Eric Blom,Gert R. Dohle,Leendert H. J. Looijenga,Wiggert A. van Cappellen,Esther B. Baart,Willy M. Baarends	13
12	Improved Progression Prediction in Barrett’s Esophagus With Low-grade Dysplasia Using Specific Histologic Criteria 2018 ·The American Journal of Surgical Pathology ·(unknown),Daan Nieboer,Fiebo J.W. ten Kate,Michail Doukas,Marco J. Bruno,Manon C.W. Spaander,Leendert H. J. Looijenga,Katharina Biermann	14
13	EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors 2018 ·Molecular Cancer Therapeutics ·Kenneth Chen,(unknown),Abhay A. Shukla,Emily K. Stroup,(unknown),(unknown),(unknown),Kiyoshi Yamaguchi,Payal Kapur,A. Lindsay Frazier,Lawrence Lum,Leendert H. J. Looijenga,Theodore W. Laetsch,Dinesh Rakheja,James F. Amatruda	11
14	Clinical utility of plasma miR‐371a‐3p in germ cell tumors 2018 ·Journal of Cellular and Molecular Medicine ·Michal Mego,Ton van Agthoven,Paulina Gronesova,Michal Chovanec,Věra Miškovská,Jozef Mardiak,Leendert H. J. Looijenga	52
15	microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients 2017 ·Cellular Oncology ·Ton van Agthoven,W M H Eijkenboom,Leendert H. J. Looijenga	62
16	Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline 2013 ·Proceedings of the National Academy of Sciences ·Eleni Giannoulatou,Gil McVean,Indira B. Taylor,Simon J. McGowan,Geoffrey J. Maher,Zamin Iqbal,Susanne P. Pfeifer,Isaac Turner,(unknown),(unknown),(unknown),Karen Turner,Lorna Gregory,David Buck,Ewa Rajpert‐De Meyts,Leendert H. J. Looijenga,Bronwyn Kerr,Andrew O.M. Wilkie,Anne Goriely	58
17	Identification of Lineage-Uncommitted, Long-Lived, Label-Retaining Cells in Healthy Human Esophagus and Stomach, and in Metaplastic Esophagus 2012 ·Gastroenterology ·Qiuwei Pan,Anna M. Nicholson,Hugh Barr,(unknown),George D. Wilson,Julia Burkert,Rosemary Jeffery,Malcolm Alison,Leendert H. J. Looijenga,Wey‐Ran Lin,Stuart A.C. McDonald,Nicholas A. Wright,Rebecca Harrison,Maikel P. Peppelenbosch,Janusz Jankowski	54
18	Microsatellite Instability, Mismatch Repair Deficiency, and BRAF Mutation in Treatment-Resistant Germ Cell Tumors 2009 ·Journal of Clinical Oncology ·Friedemann Honecker,Hendrik Wermann,Frank Mayer,Ad Gillis,Hans Stoop,(unknown),Karin Oechsle,Ewout W. Steyerberg,(unknown),Winand N.M. Dinjens,J. Wolter Oosterhuis,Carsten Bokemeyer,Leendert H. J. Looijenga	134
19	Critical Function of AP-2gamma/TCFAP2C in Mouse Embryonic Germ Cell Maintenance1 2009 ·Biology of Reproduction ·Susanne N. Weber,Dawid Eckert,Daniel Nettersheim,Ad Gillis,Sabine Schäfer,Peter Kuckenberg,(unknown),Uwe Werling,Katharina Biermann,Leendert H. J. Looijenga,Hubert Schorle	154
20	Genomic and Expression Profiling of Human Spermatocytic Seminomas: Primary Spermatocyte as Tumorigenic Precursor and DMRT1 as Candidate Chromosome 9 Gene 2006 ·Cancer Research ·Leendert H. J. Looijenga,Remko Hersmus,Ad Gillis,Rolph Pfundt,Hans Stoop,Ruud J. H. L. M. van Gurp,Joris A. Veltman,H. Berna Beverloo,Ellen van Drunen,Ad Geurts van Kessel,Renee A. Reijo Pera,Dominik T. Schneider,Brenda Summersgill,Janet Shipley,Alan McIntyre,Peter J. van der Spek,Eric Schoenmakers,J. Wolter Oosterhuis	170

About Leendert H. J. Looijenga

Leendert H. J. Looijenga is a scholar working on Reproductive Medicine, Surgery and Genetics, having authored 385 papers that have together received 19.9k indexed citations. Recurring topics across this work include Testicular diseases and treatments (236 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (82 papers) and Sexual Differentiation and Disorders (79 papers). The work is most often cited by research in Reproductive Medicine (3.8k citations), Surgery (9.9k citations) and Urology (1.2k citations). Leendert H. J. Looijenga has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include J. Wolter Oosterhuis, Hans Stoop, Ad Gillis, Martine Cools, Katja P. Wolffenbuttel, Carsten Bokemeyer, Remko Hersmus, Friedemann Honecker, Stenvert L. S. Drop and Katharina Biermann. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact